IMR Press / EJGO / Volume 29 / Issue 5 / pii/1631004266795-585895491

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Case Report
A case of extremely chemoresistant pure pleomorphic rhabdomyosarcoma of the uterus associated with a high serum LDH level
Show Less
1 Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo (Japan)
2 Central Laboratory, Shimane University School of Medicine, Izumo (Japan)
Eur. J. Gynaecol. Oncol. 2008, 29(5), 518–522;
Published: 10 October 2008

Background: Pleomorphic rhabdomyosarcoma (RMS) of gynecologic origin is an exceedingly rare, highly malignant tumor. Only a few cases have been reported in the last decades. Case report: A 60-year-old postmenopausal woman presented with a high LDH level of unknown origin. Ultimately, she was diagnosed with pleomorphic RMS. She underwent total hysterectomy, bilateral salpingo- oophorectomy, left pelvic and paraaortic lymphadenectomy and partial omentectomy. Surgery was followed by systemic chemotherapy and pelvic irradiation. Unfortunately, the patient did not respond to treatment. Her disease course correlated with the fluctuation of plasma LDH levels. Ultimately she died within 20 months of the diagnosis. Conclusion: It is important to have better insight and to set a standard multimodal treatment for adult RMS. In addition, plasma LDH levels can be considered as a prognostic marker for RMS, particularly in advanced stage.
Uterine sarcoma
Uterine rhabdomyosarcoma
Lactate dehydrogenase
Back to top